Cargando…
Inhibiting Fatty Acid Amide Hydrolase Ameliorates Enteropathy in Diabetic Mice: A Cannabinoid 1 Receptor Mediated Mechanism
SIMPLE SUMMARY: Gastrointestinal (GI) disorder is a debilitating complication of diabetes that interferes with the quality of life of the patients and current medical treatments are not very effective. High blood glucose levels in diabetics and the duration of diabetes could lead to complications of...
Autores principales: | Thakur, Vikram, Bashashati, Mohammad, Enriquez, Josue, Chattopadhyay, Munmun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319435/ https://www.ncbi.nlm.nih.gov/pubmed/35878381 http://dx.doi.org/10.3390/vetsci9070364 |
Ejemplares similares
-
Cannabinoid Receptor 1 and Fatty Acid Amide Hydrolase Contribute to Operant Sensation Seeking in Mice
por: Helfand, Alexander I., et al.
Publicado: (2017) -
Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons
por: Lueneberg, Kathia, et al.
Publicado: (2011) -
Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis
por: Rieck, Sarah, et al.
Publicado: (2021) -
Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty
Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018) -
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice
por: Cassano, Tommaso, et al.
Publicado: (2010)